2022 Enforcement Outlook: Focus on Healthcare Fraud


Healthcare enforcement saw an uptick in 2021 and in the first quarter of 2022 as the Department of Justice and other agencies ramped up their investigations following the COVID-19 slowdowns. This uptick in enforcement, combined with rulemaking and additional guidance, has given the healthcare industry much to monitor.

In this session, our healthcare-focused white-collar lawyers take a deep dive into the top issues impacting the healthcare industry today, and how leaders can proactively respond to these challenges and mitigate their enforcement risk, including:

  • Implications of the Allergan decision for future False Claims Act cases
  • State of COVID-19 enforcement
  • Use of sub-regulatory guidance in enforcement matters, including the Garland Memo, the Good Guidance Rule and others
  • Latest on opioids from the Centers for Disease Control

Dig Deeper

Paris, France / McDermott Event / October 18, 2022

European Healthcare & Life Sciences Forum

London, United Kingdom / McDermott Event / September 29, 2022

HPE Europe 2022

Arlington, VA / National Vaccine Law Conference / September 15-16, 2022

National Vaccine Law Conference

Washington, DC / 340B Coalition Summer Conference / August 1-3, 2022

340B Coalition Summer Conference

Nashville, TN / HealthTrust / July 25-26, 2022

HealthTrust University Conference

Chicago, IL / McDermott Event / June 28, 2022

McDermott's Annual AHLA Meeting Reception 2022

Get In Touch